CD8A and neoplasm: PD-1 blockade reinvigorates exhausted CD8 T cells; this mechanism of action likely extends to other subsets and is not restricted to the tumor microenvironment, but depends on immunomodulation of the peripheral blood and lymphoid compartment.57